TY - JOUR
T1 - Human SULT1A1 gene
T2 - Copy number differences and functional implications
AU - Hebbring, Scott J.
AU - Adjei, Araba A.
AU - Baer, Janel L.
AU - Jenkins, Gregory D.
AU - Zhang, Jianping
AU - Cunningham, Julie M.
AU - Schaid, Daniel J.
AU - Weinshilboum, Richard M.
AU - Thibodeau, Stephen N.
N1 - Funding Information:
Supported in part by National Institute of Health grants R01 GM28157, R01 GM35720 and U01 GM61388 (A.A.A., J.L.B., J.Z., R.M.W.) and by Prostate SPORE CA91956 (S.J.H., J.M.C., S.K.M., D.J.S., S.N.T.). Funding to pay the Open Access publication charges for this article was provided by the Department of Laboratory Medicine and Pathology.
PY - 2007/3/1
Y1 - 2007/3/1
N2 - SULT1A1, which catalyzes the sulfate conjugation of a wide variety of natural and synthetic compounds, is genetically polymorphic. Biochemical and pharmacogenetic studies have demonstrated that individual variation in the level of enzyme activity is inherited. Common single-nucleotide polymorphisms (SNPs) located in the open reading frame and in the 5′-flanking region (5′-FR) may account for a portion of this individual variation. In this study, we demonstrate the presence of SULT1A1 gene deletions and duplications, representing an additional source of variability in the metabolic activity of this enzyme. A quantitative multiplex PCR assay was used to measure the extent of copy number differences and the frequency of these events in different populations. An analysis of DNA from 362 Caucasian-American and 99 African-American showed the presence of 1 to ∼5 copies of SULT1A1 in individual samples: 5% of Caucasian subjects contained a single copy of the gene and 26% had three or more copies, while 63% of African-American subjects had three or more copies. Analysis of the genomic region surrounding the SULT1A1 gene in three separate cases with a deletion demonstrated that the entire SULT1A1 gene was affected. Reporter assays, constructed for each of the various 5′-FR SNP haplotypes, suggest that these may also play a role in SULT1A1 activity. However, the variability in the level of enzyme activity among 23 human platelet and 267 human liver samples was best explained by gene copy number differences when all sources of genetic variability were considered (P < 0.0001). Overall, these observations have obvious implications for the effectiveness of SULT1A1 as a drug and hormone metabolizing enzyme and its potential role as a risk factor for disease.
AB - SULT1A1, which catalyzes the sulfate conjugation of a wide variety of natural and synthetic compounds, is genetically polymorphic. Biochemical and pharmacogenetic studies have demonstrated that individual variation in the level of enzyme activity is inherited. Common single-nucleotide polymorphisms (SNPs) located in the open reading frame and in the 5′-flanking region (5′-FR) may account for a portion of this individual variation. In this study, we demonstrate the presence of SULT1A1 gene deletions and duplications, representing an additional source of variability in the metabolic activity of this enzyme. A quantitative multiplex PCR assay was used to measure the extent of copy number differences and the frequency of these events in different populations. An analysis of DNA from 362 Caucasian-American and 99 African-American showed the presence of 1 to ∼5 copies of SULT1A1 in individual samples: 5% of Caucasian subjects contained a single copy of the gene and 26% had three or more copies, while 63% of African-American subjects had three or more copies. Analysis of the genomic region surrounding the SULT1A1 gene in three separate cases with a deletion demonstrated that the entire SULT1A1 gene was affected. Reporter assays, constructed for each of the various 5′-FR SNP haplotypes, suggest that these may also play a role in SULT1A1 activity. However, the variability in the level of enzyme activity among 23 human platelet and 267 human liver samples was best explained by gene copy number differences when all sources of genetic variability were considered (P < 0.0001). Overall, these observations have obvious implications for the effectiveness of SULT1A1 as a drug and hormone metabolizing enzyme and its potential role as a risk factor for disease.
UR - http://www.scopus.com/inward/record.url?scp=34047124906&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34047124906&partnerID=8YFLogxK
U2 - 10.1093/hmg/ddl468
DO - 10.1093/hmg/ddl468
M3 - Article
C2 - 17189289
AN - SCOPUS:34047124906
SN - 0964-6906
VL - 16
SP - 463
EP - 470
JO - Human molecular genetics
JF - Human molecular genetics
IS - 5
ER -